These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37863912)

  • 1. White targeted chromatographic screening method of Molnupiravir and its metabolite with degradation kinetics characterization and in-silico toxicity.
    Aboras SI; Megahed AA; El-Yazbi F; Maher HM
    Sci Rep; 2023 Oct; 13(1):17919. PubMed ID: 37863912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green adherent degradation kinetics study of Nirmatrelvir, an oral anti-COVID-19: characterization of degradation products using LC-MS with insilico toxicity profile.
    Aboras SI; Maher HM
    BMC Chem; 2023 Mar; 17(1):23. PubMed ID: 36932440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainable Stability-Indicating spectra manipulations for the concurrent quantification of a novel Anti-COVID-19 drug and its active Metabolite: Green profile assessment.
    Gamal Fawzy M; Kamel EB
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Nov; 300():122911. PubMed ID: 37267836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS.
    Wróblewski K; Szultka-Młyńska M; Janiszewska D; Petruczynik A; Buszewski B
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative DNA Damage by N4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir.
    Kobayashi H; Mori Y; Ahmed S; Hirao Y; Kato S; Kawanishi S; Murata M; Oikawa S
    J Infect Dis; 2023 Apr; 227(9):1068-1072. PubMed ID: 36461940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied using nanoformulations in permeability studies.
    Reçber T; Timur SS; Erdoğan Kablan S; Yalçın F; Karabulut TC; Neslihan Gürsoy R; Eroğlu H; Kır S; Nemutlu E
    J Pharm Biomed Anal; 2022 May; 214():114693. PubMed ID: 35276385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison.
    Geven A; Özcan S; Levent S; Can NÖ
    J AOAC Int; 2023 Sep; 106(5):1145-1153. PubMed ID: 37348556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sustainable approach for the degradation kinetics study and stability assay of the SARS-CoV-2 oral antiviral drug Molnupiravir.
    Edrees FH; Draz ME; Saad AS; Hammad SF; Mohamed HM
    Sci Rep; 2023 May; 13(1):8797. PubMed ID: 37258556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation kinetics and characterization of major degradants of binimetinib employing liquid chromatography-high resolution mass spectrometry.
    Rajput N; Soni F; Sahu AK; Jadav T; Sharma S; Sengupta P
    J Pharm Biomed Anal; 2022 Jun; 215():114753. PubMed ID: 35447490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultraviolet-photodiode array and high-performance liquid chromatographic/mass spectrometric studies on forced degradation behavior of glibenclamide and development of a validated stability-indicating method.
    Bansal G; Singh M; Jindal KC; Singh S
    J AOAC Int; 2008; 91(4):709-19. PubMed ID: 18727528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
    Bansal G; Singh R; Saini B; Bansal Y
    J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer and biotransformation of the COVID-19 prodrug molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-placenta barrier.
    Chang CH; Peng WY; Lee WH; Lin TY; Yang MH; Dalley JW; Tsai TH
    EBioMedicine; 2023 Sep; 95():104748. PubMed ID: 37544201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir.
    Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
    Ann Pharm Fr; 2017 May; 75(3):176-184. PubMed ID: 28187879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stability indicating HPLC method for the determination of clobazam and its basic degradation product characterization.
    Souri E; Farahani AD; Ahmadkhaniha R; Amini M
    Daru; 2014 Jun; 22(1):49. PubMed ID: 24919821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a stability-indicating assay method by HPLC-DAD and MS characterization of forced degradation products of ravuconazole.
    Gazzinelli BP; Brêtas CM; César IC
    J Chromatogr Sci; 2022 Feb; 60(2):157-163. PubMed ID: 34075394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
    Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation kinetics study of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) by a validated stability-indicating RP-HPLC method.
    Kim KS; Yang ES; Kim DS; Kim DW; Yong CS; Kim JO; Jin SG; Choi HG
    J Pharm Biomed Anal; 2018 Feb; 149():374-380. PubMed ID: 29145099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UHPLC-DAD Method Development and Validation: Degradation Kinetic, Stress Studies of Farnesol and Characterization of Degradation Products Using LC-QTOF-ESI-MS with in silico Pharmacokinetics and Toxicity Predictions.
    Moinuddin SK; Gajbhiye RL; Mehta P; Sarmah B; Murty US; Ravichandiran V; Samudrala PK; Alexander A; Kumar P
    J Chromatogr Sci; 2022 Nov; 60(9):817-831. PubMed ID: 34849633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva.
    Amara A; Penchala SD; Else L; Hale C; FitzGerald R; Walker L; Lyons R; Fletcher T; Khoo S
    J Pharm Biomed Anal; 2021 Nov; 206():114356. PubMed ID: 34509661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.